XML 39 R30.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock Option (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2022
2012 Employee Stock Option Plan |
Stock Option |
Schedule of fair value and valuation assumptions | ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |
Risk-free interest rates | ​ | 1.64 | % | n/a | %
Expected lives | ​ | 6.18 Years | ​ | n/a | ​
Expected volatility | ​ | 43 | % | n/a | %
Expected dividend yields | ​ | 0 | % | n/a | %
Schedule of plan activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 | ​ | 2021 | ​
​ | ​ | ​ | ​ | ​ | Weighted average | ​ | ​ | ​ | ​ | Weighted average | ​
​ |  | Options |  | exercise price |  | Options |  | exercise price |
Outstanding, beginning of year | ​ | ​ | 214,080 | ​ | $ | 9.59 | ​ | ​ | 235,680 | ​ | $ | 9.42 | ​
Granted | ​ | ​ | 338,000 | ​ | $ | 23.17 | ​ | ​ | — | ​ | ​ | — | ​
Forfeited/Lapsed | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (8,000) | ​ | $ | 4.08 | ​
Exercised | ​ | ​ | (29,000) |  | $ | 5.45 | ​ |  | (3,600) |  | $ | 5.70 | ​
Outstanding, end of period | ​ | ​ | 523,080 | ​ | $ | 18.59 | ​ |  | 224,080 | ​ | $ | 9.67 | ​
Exercisable, end of period | ​ | ​ | 164,776 | ​ | $ | 15.01 | ​ |  | 89,200 | ​ | $ | 7.92 | ​
Weighted average fair value at grant date of options granted | ​ | $ | 12.16 | ​ |  | ​ | ​ | ​ | n/a | ​ |  | ​ | ​
Total intrinsic value of options exercised | ​ | $ | 502,000 | ​ | ​ | ​ | ​ | $ | 42,000 | ​ |  | ​ | ​
Total intrinsic value of options outstanding | ​ | $ | 1,903,000 | ​ | ​ | ​ | ​ | $ | 1,735,000 | ​ |  | ​ | ​
Total intrinsic value of options exercisable | ​ | $ | 1,085,000 | ​ | ​ | ​ | ​ | $ | 847,000 | ​ |  | ​ | ​
Schedule of options outstanding | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Options outstanding | ​ | Options exercisable
​ |  | ​ |  | Weighted average |  | ​ | ​ |  | ​ |  | ​ | ​
​ | ​ | Number | ​ | remaining | ​ | Weighted average | ​ | Number | ​ | Weighted average
Range of exercise prices | ​ | outstanding | ​ | contractual life | ​ | exercise price | ​ | exercisable | ​ | exercise price
$2.19 ‑ $24.75 | ​ | 523,080 | ​ | 8.67 | ​ | $ | 18.59 | ​ | 164,776 | ​ | $ | 15.01
​ | ​ | 523,080 | ​ | 8.67 | ​ | $ | 18.59 | ​ | 164,776 | ​ | $ | 15.01
2012 Non-Employee Stock Option Plan |
Stock Option |
Schedule of fair value and valuation assumptions | ​
​ | ​ | ​ | ​ | ​
​ | 2022 |  | 2021 |
Risk-free interest rates | 1.68 | % | n/a | %
Expected lives | 6.18 Years | ​ | n/a | ​
Expected volatility | 43 | % | n/a | %
Expected dividend yields | 0 | % | n/a | %
Schedule of plan activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 | ​ | 2021 | ​
​ |  | ​ | ​ |  | Weighted average |  | ​ | ​ |  | Weighted average |
​ | ​ | Options | ​ | exercise price | ​ | Options | ​ | exercise price | ​
Outstanding, beginning of year | ​ | ​ | 12,000 | ​ | $ | 6.55 | ​ | ​ | 24,000 | ​ | $ | 5.15 | ​
Granted | ​ | ​ | 9,600 | ​ | $ | 22.93 | ​ | ​ | — | ​ | ​ | — | ​
Forfeited/Lapsed | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
Exercised | ​ | ​ | — | ​ | ​ | — | ​ |  | (2,400) |  | $ | 4.35 | ​
Outstanding, end of period | ​ | ​ | 21,600 | ​ | $ | 13.83 | ​ |  | 21,600 | ​ | $ | 5.23 | ​
Exercisable, end of period | ​ | ​ | 12,480 | ​ | $ | 8.48 | ​ |  | 14,640 | ​ | $ | 4.57 | ​
Weighted average fair value at grant date of options granted | ​ | $ | 12.58 | ​ | ​ | ​ | ​ | ​ | n/a | ​ |  |  | ​
Total intrinsic value of options exercised | ​ | ​ | n/a | ​ | ​ | ​ | ​ | $ | 31,000 | ​ |  |  | ​
Total intrinsic value of options outstanding | ​ | $ | 168,000 | ​ | ​ | ​ | ​ | $ | 263,000 | ​ |  |  | ​
Total intrinsic value of options exercisable | ​ | $ | 155,000 | ​ | ​ | ​ | ​ | $ | 188,000 | ​ |  |  | ​
Schedule of options outstanding | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Options outstanding | ​ | Options exercisable
​ | ​ | ​ | ​ | Weighted average | ​ | Weighted | ​ | ​ | ​ | Weighted
​ | ​ | Number | ​ | remaining | ​ | average exercise | ​ | Number | ​ | average exercise
Range of exercise prices | ​ | outstanding |  | contractual life | ​ | price |  | exercisable | ​ | price
$4.35 - $22.93 | ​ | 21,600 | ​ | 7.78 | ​ | $ | 13.83 | ​ | 12,480 | ​ | $ | 8.48
​ | ​ | 21,600 | ​ | 7.78 | ​ | $ | 13.83 | ​ | 12,480 | ​ | $ | 8.48
2018 Non-Employee Stock Option Plan |
Stock Option |
Schedule of fair value and valuation assumptions | ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 |  | 2021 |
Risk-free interest rates | ​ | 1.68 | % | n/a | %
Expected lives | ​ | 6.18 Years | ​ | n/a | ​
Expected volatility | ​ | 43 | % | n/a | %
Expected dividend yields | ​ | 0 | % | n/a | %
Schedule of plan activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 | ​ | 2021 | ​
​ |  | ​ | ​ |  | Weighted average |  | ​ | ​ |  | Weighted average |
​ | ​ | Options |  | exercise price | ​ | Options |  | exercise price | ​
Outstanding, beginning of year | ​ | ​ | 70,100 | ​ | $ | 11.93 | ​ | ​ | 96,800 | ​ | $ | 11.74 | ​
Granted | ​ | ​ | 23,500 |  | $ | 22.93 | ​ |  | — |  | ​ | — | ​
Forfeited/Lapsed | ​ | ​ | — |  | ​ | — | ​ |  | — |  | ​ | — | ​
Exercised | ​ | ​ | (4,600) |  | $ | 10.43 | ​ |  | (3,200) |  | $ | 8.10 | ​
Outstanding, end of period | ​ | ​ | 89,000 | ​ | $ | 14.91 | ​ |  | 93,600 | ​ | $ | 11.87 | ​
Exercisable, end of period | ​ | ​ | 45,040 | ​ | $ | 12.98 | ​ |  | 40,960 | ​ | $ | 11.54 | ​
Weighted average fair value at grant date of options granted | ​ | $ | 12.58 | ​ | ​ | ​ | ​ | ​ | n/a | ​ | ​ | ​ | ​
Total intrinsic value of options exercised | ​ | $ | 58,000 | ​ | ​ | ​ | ​ | $ | 30,000 | ​ | ​ | ​ | ​
Total intrinsic value of options outstanding | ​ | $ | 556,000 | ​ | ​ | ​ | ​ | $ | 519,000 | ​ | ​ | ​ | ​
Total intrinsic value of options exercisable | ​ | $ | 351,000 | ​ | ​ | ​ | ​ | $ | 241,000 | ​ | ​ | ​ | ​
Schedule of options outstanding | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Options outstanding | ​ | Options exercisable
​ |  | ​ |  | Weighted average |  | Weighted |  | ​ |  | Weighted
​ | ​ | Number | ​ | remaining | ​ | average exercise | ​ | Number | ​ | average exercise
Range of exercise prices | ​ | outstanding | ​ | contractual life | ​ | price | ​ | exercisable | ​ | price
$8.10 - $22.93 | ​ | 89,000 |  | 8.00 | ​ | $ | 14.91 |  | 45,040 | ​ | $ | 12.98
​ | ​ | 89,000 |  | 8.00 | ​ | $ | 14.91 |  | 45,040 | ​ | $ | 12.98
2020 Non-Employee Stock Option Plan |
Stock Option |
Schedule of fair value and valuation assumptions | ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |
Risk-free interest rates |  | 1.68 | % | 0.62 | %
Expected lives |  | 6.18 Years | ​ | 10 | ​
Expected volatility |  | 43 | % | 45 | %
Expected dividend yields |  | 0 | % | 0 | %
Schedule of plan activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 | ​ | 2021 | ​
​ | ​ | ​ | ​ | ​ | Weighted average | ​ | ​ | ​ | ​ | Weighted average | ​
​ |  | Options |  | exercise price | ​ | Options |  | exercise price | ​
Outstanding, beginning of year |  | ​ | 10,000 |  | $ | 11.40 | ​ | ​ | — |  | ​ | — | ​
Granted |  | ​ | 16,900 | ​ | $ | 22.93 | ​ | ​ | 10,000 | ​ | $ | 11.40 | ​
Forfeited/Lapsed | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
Exercised |  | ​ | — | ​ |  | — | ​ | ​ | — | ​ |  | — | ​
Outstanding, end of period |  | ​ | 26,900 | ​ | $ | 18.64 | ​ | ​ | 10,000 | ​ | $ | 11.40 | ​
Exercisable, end of period |  | ​ | 7,380 | ​ | $ | 16.68 | ​ | ​ | 2,000 | ​ | $ | 11.40 | ​
Weighted average fair value at grant date of options granted | ​ | $ | 12.58 | ​ |  |  | ​ | $ | 6.10 | ​ |  | ​ | ​
Total intrinsic value of options exercised | ​ |  | n/a | ​ |  |  | ​ |  | n/a | ​ |  | ​ | ​
Total intrinsic value of options outstanding | ​ | $ | 91,000 | ​ |  |  | ​ | $ | 60,000 | ​ |  | ​ | ​
Total intrinsic value of options exercisable | ​ | $ | 36,000 | ​ |  |  | ​ | $ | 12,000 | ​ |  | ​ | ​
Schedule of options outstanding | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Options outstanding | ​ | Options exercisable
​ | ​ | ​ | ​ | Weighted average | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Number | ​ | remaining | ​ | Weighted average | ​ | Number | ​ | Weighted average
Range of exercise prices |  | outstanding |  | contractual life |  | exercise price |  | exercisable |  | exercise price
$11.40 - $22.93 |  | 26,900 |  | 9.14 | ​ | $ | 18.64 |  | 7,380 | ​ | $ | 16.68
​ |  | 26,900 |  | 9.14 | ​ | $ | 18.64 |  | 7,380 | ​ | $ | 16.68

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=nssc_Employee2012StockOptionPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=nssc_Nonemployee2012StockOptionPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=nssc_Nonemployee2018StockOptionPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=nssc_Nonemployee2020StockOptionPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |